ArticleThe Journal of molecular diagnostics : JMD2026
Diagnostic Utility of Single Nucleotide Polymorphism Microarray in Evaluating Pancreaticobiliary Brushing Specimens in Conjunction with Conventional Cytology.
Article in The Journal of molecular diagnostics : JMD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bile duct brushings are noninvasive samplings of cells from the biliary tract for cytologic evaluation and are useful to diagnose pancreaticobiliary malignancies. Although specificity of cytology is satisfactory, sensitivity is inherently low because of challenging or absent morphologic features. Using molecular markers by incorporating fluorescence in situ hybridization has significantly improved sensitivity and diagnosis. To further advance the use of molecular markers, OncoScan microarray was used, which has genome-wide coverage and significantly higher resolution compared with fluorescence in situ hybridization. This study tested 128 pancreaticobiliary brushing specimens with OncoScan and compared them with cytology while using the biopsy of these patients as a reference. OncoScan was able to detect more malignant cases compared with cytology. In addition, the study identified potential molecular markers that have not been previously studied or reported. This study demonstrates that OncoScan is a useful additional diagnostic tool with cytology for pancreaticobiliary brushing specimens by improving the sensitivity to detect malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.